GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Wuhan Easy Diagnosis Biomedicine Co Ltd (SZSE:002932) » Definitions » FCF Yield %

Wuhan Easy Diagnosis Biomedicine Co (SZSE:002932) FCF Yield % : 15.15 (As of Jun. 21, 2024)


View and export this data going back to 2018. Start your Free Trial

What is Wuhan Easy Diagnosis Biomedicine Co FCF Yield %?

FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

As of today, Wuhan Easy Diagnosis Biomedicine Co's Trailing 12-Month Free Cash Flow is ¥629.7 Mil, and Market Cap is ¥4,157.5 Mil. Therefore, Wuhan Easy Diagnosis Biomedicine Co's FCF Yield % for today is 15.15%.

The historical rank and industry rank for Wuhan Easy Diagnosis Biomedicine Co's FCF Yield % or its related term are showing as below:

SZSE:002932' s FCF Yield % Range Over the Past 10 Years
Min: -0.39   Med: 7.22   Max: 76.54
Current: 15.15


During the past 13 years, the highest FCF Yield % of Wuhan Easy Diagnosis Biomedicine Co was 76.54%. The lowest was -0.39%. And the median was 7.22%.

SZSE:002932's FCF Yield % is ranked better than
97.58% of 866 companies
in the Medical Devices & Instruments industry
Industry Median: -2.82 vs SZSE:002932: 15.15

Wuhan Easy Diagnosis Biomedicine Co's FCF Margin % for the quarter that ended in Mar. 2024 was -25.84%.


Wuhan Easy Diagnosis Biomedicine Co FCF Yield % Historical Data

The historical data trend for Wuhan Easy Diagnosis Biomedicine Co's FCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Wuhan Easy Diagnosis Biomedicine Co FCF Yield % Chart

Wuhan Easy Diagnosis Biomedicine Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
FCF Yield %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.39 7.62 13.19 41.36 5.29

Wuhan Easy Diagnosis Biomedicine Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
FCF Yield % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -16.80 6.69 24.46 15.33 -1.24

Competitive Comparison of Wuhan Easy Diagnosis Biomedicine Co's FCF Yield %

For the Medical Devices subindustry, Wuhan Easy Diagnosis Biomedicine Co's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Wuhan Easy Diagnosis Biomedicine Co's FCF Yield % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Wuhan Easy Diagnosis Biomedicine Co's FCF Yield % distribution charts can be found below:

* The bar in red indicates where Wuhan Easy Diagnosis Biomedicine Co's FCF Yield % falls into.



Wuhan Easy Diagnosis Biomedicine Co FCF Yield % Calculation

FCF Yield % is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

Wuhan Easy Diagnosis Biomedicine Co's FCF Yield % for the fiscal year that ended in Dec. 2023 is calculated as

FCF Yield %=Free Cash Flow / Market Cap
=282.524 / 5341.00737
=5.29%

Wuhan Easy Diagnosis Biomedicine Co's annualized FCF Yield % for the quarter that ended in Mar. 2024 is calculated as

FCF Yield %=Free Cash Flow * Annualized Factor / Market Cap
=-15.75 * 4 / 5064.30738
=-1.24%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Wuhan Easy Diagnosis Biomedicine Co FCF Yield % Explanation

Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.


Wuhan Easy Diagnosis Biomedicine Co FCF Yield % Related Terms

Thank you for viewing the detailed overview of Wuhan Easy Diagnosis Biomedicine Co's FCF Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.


Wuhan Easy Diagnosis Biomedicine Co (SZSE:002932) Business Description

Traded in Other Exchanges
N/A
Address
No. 1 Dongxin Road, 2 Floor, Building E, International Students Pioneer Park, Guandong Science and Technology Park, Donghu Development Zone, Hubei, Wuhan, CHN, 430075
Wuhan Easy Diagnosis Biomedicine Co Ltd is engaged in the research and development, production and sales of in vitro diagnostic reagents and supporting instruments and mobile ECG products. The company's product profile consists of Molecular diagnosis, Chemiluminescence, Blood gas analysis, and others. It also provides various other solutions such as Mingde Biomolecular Diagnostic Service Solution, Mingde Biothoracic Center Solution, POCT Solution, Remote ECG network construction solution, and others.
Executives
Wang Rui Directors, executives
Wang Jian Fei Director

Wuhan Easy Diagnosis Biomedicine Co (SZSE:002932) Headlines

No Headlines